2Ohta T, Komoriya S,Yoshino T, et al. Preparation ofN,N'-b\s (heterocyclicacyl) cycloalkanediamine andheterocyclediamine derivatives as inhibitors of activatedblood coagulation factor X (factor Xa): WO, 2003 000657[P]. 2003-01-03. (CA2003,138: 73271).
3Ohta T, Komoriya S,Yoshino T, et al. Preparation ofheterocyclic moiety-containing diamine derivatives as FXainhibitors: WO, 2003 000680 [P], 2003-01-03. (CA 2003,138:89801).
4Mochizuki A, Nagata T. Triamine derivative: WO,2006106963 [P]. 2005-03-31. (CA2006,145: 419128).
5Kawanami K,Ishikawa H, Shoji M. Process for preparationof optically active (15,3^,4/^) -3-amino-4-hydroxy-A^,7V-dimethylcyclohexanecarboxamide derivative salt: WO,2012002538 [P]. 2012-01-05. (CA 2012,156: 122056).
6Sato K, Kubota K. Process for producing optically activecarboxylic acid: WO, 2010067824 [P]. 2010-06-17. (CA2010,153: 36882).
7Yoshikawa K, Yokomizo A, Naito H, et al. Design, synthesis,and SARof cis-1,2-diaminocyclohexane derivatives as potentfactor Xa inhibitors. Part I: Exploration of 5-6fused ringsas alternative SI moieties [J]. Bioorg Med Chem, 2009,17(24):8206-8220.
8Sato K, Kawanami K, Yagi T. Process for the preparation ofoptically active cyclohexane-1,2-diamine derivative from7-oxabicyclo [4.1.0] heptane compound: WO, 2007032498[P]. 2007-03-22. (CA2007,146: 358502).
9Kawanami K. Method for the preparation of optically activediamine derivative: WO, 2010104106 [P]. 2010-09-16. (CA2010,153: 406061).
10Koyama T, Kondo S. Process for the preparation of diaminederivative: WO, 2010104078 [P]. 2010-09-16. (CA 2010,153:382938).
